A 37 percent high quality over the closing stock price on Friday October 21.

We are thrilled to announce this deal with Cigna, stated Herb Fritch. Carrying out a review undertaken by our Board of Directors of the company’s strategic options, we concluded that the mixture is in the best interests of our shareholders. The combination may also expand our ability to serve our doctor partners and customers. Cigna recognizes the value in HealthSpring’s differentiated model of physician engagement, and shares our commitment to providing top quality, affordable care to the associates and communities we serve. We anticipate continuing and growing upon this mission truly. The combination provides Cigna with many significant opportunities to further expand upon its successful growth strategy: Scaled existence in the highly-attractive Seniors segment, with a differentiated Medicare Benefit business that presently has approximately 340 extremely, 000 Medicare Advantage users in 11 Washington and states, D.C., as well as a large, nationwide stand-alone Medicare prescription medication business with over 800,000 customers; One of the most trusted and well-respected brands offering Seniors quality care through its highly differentiated physician partnerships; Future growth opportunities to expand HealthSpring’s consumer base by leveraging Cigna’s current customer relationships also to further the growth of HealthSpring into fresh geographic regions, leveraging Cigna’s nationwide existence, customer bottom and distribution capabilities; Capability to give Cigna’s current industrial and individual clients the opportunity to experience HealthSpring’s differentiated doctor coordination model; and additional leverage Cigna’s diverse portfolio of specialty applications for the advantage of HealthSpring’s customers.‘We're so proud to accept this award that recognizes the contribution of each and every Building Strides and Relay for Life group in the Kroger family. These new screws represent the most recent advance in biocomposite materials technology that allows CONMED Linvatec to create the smallest Biocomposite Interference screw available on the market today for main fixation of ACL and PCL grafts. The Company will debut the product at the Fall Arthroscopy Association of THE UNITED STATES achieving in Palm Springs, CA, november 19-21 which takes place, 2009. Interference screw fixation is frequently used to attach replacing ligaments in tunnels drilled for anterior and posterior cruciate ligament reconstruction.